Paragon and NextDocs Introduce Clinical Optimization Solutions Targeting Life Sciences Firms
Paragon Solutions, a business consulting and information technology services firm, announced the launch of solutions to optimize clinical operations incorporating the NextDocs product suite. The clinical solutions combine the capabilities of the two partners to deploy low-risk, accelerated solutions for life sciences built on Microsoft Office SharePoint Server.
“With the growing adoption of SharePoint within Life Sciences organizations, companies are looking for solution accelerators that leverage enterprise platforms to optimize the end-to-end drug development process,” said Ravi Shankar, vice president of Paragon’s Life Sciences practice. “NextDocs extends SharePoint with capabilities that complement our Clinical Optimization solution strategy,” he said.
The solutions leverage a strategic partnership formed by the companies in September 2009. One of the solutions the companies are introducing as part of the Clinical Optimization Solution portfolio is an integrated investigator portal. The portal is designed to deliver a collaborative environment that enables clinical sponsors and investigators to: negotiate contracts; define and communicating protocols; support site monitoring; manage grants; work with partners; and improve oversight and planning.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
